Successfully reported this slideshow.
Your SlideShare is downloading. ×

2022 GGSD Forum- Session 3 Scene Setter-David Elvira

Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad

Check these out next

1 of 5 Ad

2022 GGSD Forum- Session 3 Scene Setter-David Elvira

Download to read offline

Scene-setting presentation by David Elvira, Head of Global Corporate Public Policy, Sanofi at the 2022 GGSD Forum, Session 3 "International co-operation to accelerate green technology innovation and transfer"

Scene-setting presentation by David Elvira, Head of Global Corporate Public Policy, Sanofi at the 2022 GGSD Forum, Session 3 "International co-operation to accelerate green technology innovation and transfer"

Advertisement
Advertisement

More Related Content

More from OECD Environment (20)

Recently uploaded (20)

Advertisement

2022 GGSD Forum- Session 3 Scene Setter-David Elvira

  1. 1. International cooperation to accelerate green technology innovation and transfer OECD Green Growth and Sustainable Development Forum 2022 David Elvira, Head of Global Corporate Public Policy
  2. 2. 2 International cooperation brought unprecedented science-based solutions to the pandemic Surveillance, rapid data sharing, and access to pathogens across the scientific community was crucial in developing tests, medicines and vaccines Collaborative consultations with industry and regulators helped secure safety and efficacy of vaccines and medicines at a record pace Partnerships helped accelerate R&D and manufacturing, facilitated technology and knowledge transfer Established governance structures for advanced market commitments and procurement allowed for supplemental investments in production capacity Pre- clinical, 10 Phase I Clinical Phase II Clinical Phase III Regulato ry Approval Standard Accelerated For more details: https://coronavirus.jhu.edu/vaccines/timeline Vaccine Development Timelines (est.) ~ 10-12 years ~1-2 years Efforts at clinical trials’ level, fast track regulatory process, joint assessment of regional regulatory authorities and parallel security- safety revisions…
  3. 3. This multi-crisis era puts science and innovation at the forefront • Continuous knowledge and data sharing will be critical (e.g., in pathogen sharing and biodiversity protection) • Sustained investments in research and development will help drive innovation across sectors to bring solutions • Global regulatory and legal frameworks are key in incentivizing innovation • Partnerships and coalitions are essential in addressing global public good issues
  4. 4. 4 Accelerating green growth through the delivery of net-zero health systems Challenges Data gaps in and emission baselining of the biopharma value chain Lack of regulatory standards that account for low-carbon treatments or care delivery models Limited solutions that are economic and easily scalable 1 2 3 Seven levers to reduce emmissions in care pathways Decarbonizing facilities Improving prevention and care Decarbonizing facilities and fleets Preventing disease onset Diagnosing early Optimizing disease management Delivering care differently Improving the efficiency of interventions Delivering care remotely or closer to home when appropriate Using lower émission treatments Source: Health Care Without Harm, WHO, academic literature, BCG analysis
  5. 5. Thank you

×